Early-stage stem cell therapy trial shows promise for treating progressive MS
27 November 2023
An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.
Cambridge partners with AstraZeneca and Medical Research Council on new world-class functional genomics laboratory
27 November 2023
The facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.
Four Cambridge researchers awarded consolidator grants from the European Research Council
22 November 2023
The European Research Council (ERC) has awarded grants worth a total of €627 million to 308 researchers across Europe, of whom four are at the University of Cambridge.
© 2023 University of Cambridge
